89 results on '"Myocardial ischemia -- Drug therapy"'
Search Results
2. BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial
3. BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
4. Ischemic Heart Disease (IHD) Drugs Market Overview 2024-2028: Projected Market Size, Major Drivers And Leading Segments As Per The Business Research Company's Ischemic Heart Disease (IHD) Drugs Global Market Report 2024
5. Investigators from Shantou University College of Medicine Report New Data on Myocardial Ischemia (Mros-calcium Feedback Loop Promotes Lethal Ventricular Arrhythmias and Sudden Cardiac Death In Early Myocardial Ischemia)
6. Effect of glutamate infusion on NT-proBNP after coronary artery bypass grafting in high-risk patients (GLUTAMICS II): A randomized controlled trial
7. Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028
8. Rising Disease Awareness and Aging Population Propel Global Ischemic Heart Disease IHD Drugs Market to $6.1 Billion in 2022
9. Kangwon National University College of Medicine Researchers Update Understanding of Myocardial Ischemia (Magnetocardiography for the detection of myocardial ischemia)
10. Data from Yale University School of Medicine Provide New Insights into Myocardial Ischemia (Management of Stable Angina in the Older Adult Population)
11. Data on Myocardial Ischemia Reported by Researchers at Department of Cardiovascular Medicine (Inhibition of miR-217 Protects Against Myocardial Ischemia-Reperfusion Injury Through Inactivating NF-kB and MAPK Pathways)
12. Research from China Pharmaceutical University Broadens Understanding of Myocardial Ischemia (Characterization of a novel polysaccharide from red ginseng and its ameliorative effect on oxidative stress injury in myocardial ischemia)
13. Researchers from Duke University Report New Studies and Findings in the Area of Myocardial Ischemia (A Precision Medicine Approach To Stress Testing Using Metabolomics and Microribonucleic Acids)
14. Cardiac patch treatment alleviates ischemic cardiomyopathy correlated with reverting Piezo1/2 expression by unloading left ventricular myocardium
15. Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years
16. Study Results from Battelle Memorial Institute Broaden Understanding of Bioelectronics (Dynamic Detection and Reversal of Myocardial Ischemia Using an Artificially Intelligent Bioelectronic Medicine)
17. Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury
18. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice
19. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
20. Data from Department of Medicine Provide New Insights into Myocardial Ischemia (Incidental Finding of the Anomalous Origin of Left Main Coronary Artery from Pulmonary Artery in an Adult Presenting with Arrhythmia-Induced Myocardial Ischemia)
21. Data on Myocardial Ischemia Discussed by Researchers at China Pharmaceutical University (A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia)
22. BioCardia's CardiAMP Cell Therapy Secures FDA Approval for Pivotal Trial in Chronic Myocardial Ischemia
23. New Findings from Institute for Cancer Research and Treatment (IRCCS) in Ischemic Cardiomyopathy Provides New Insights (Cardiac Magnetic Resonance Tissue Characterization In Ischemic Cardiomyopathy)
24. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy
25. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE)
26. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics
27. A coding guide for heart disease: outlining the differences and changes in coding for ischemic heart disease in the International Classification of Diseases--10th Revisions--Clinical Management (ICD-10-CM)
28. Influence of Dalargin, a Peripheral Opiate Receptor Agonist, on Exercise Tolerance in Patients with Coronary and Peripheral Artery Atherosclerosis
29. Evaluation of antihypertensive therapy among ischemic stroke survivors: impact of ischemic heart disease
30. Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit
31. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease
32. Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease
33. New Heart Disease Study Findings Recently Were Reported by Researchers at National Heart Centre Singapore (Global Differences In Burden and Treatment of Ischemic Heart Disease In Acute Heart Failure Report-hf)
34. Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis
35. Metabolic modulators for chronic cardiac ischemia
36. A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease
37. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy
38. Antibiotics for the secondary prevention of ishemic heart disease: a meta-anlysis of randomized controlled tirals
39. Medical management of chronic ischemic heart disease: Selecting specific drug therapies, modifying risk factors
40. Effects of glucose--insulin--potassium infusion on chronic ischaemic left ventricular dysfunction. (Cardiovascular Medicine)
41. Dynamic Detection and Reversal of Myocardial Ischemia Using an Artificially Intelligent Bioelectronic Medicine (Updated March 11, 2021)
42. Dynamic Detection and Reversal of Myocardial Ischemia Using an Artificially Intelligent Bioelectronic Medicine
43. Data on Myocardial Ischemia Discussed by Researchers at National Institute of Cardiology Ignacio Chavez (Clofibrate improves myocardial ischemia-induced damage through regulation of renin-angiotensin system and favours a pro-vasodilator profile ...)
44. Effect of trapidil in myocardial ischemia-reperfusion injury in rabbit
45. Study Data from Carlos Chagas Institute Update Understanding of Ischemic Cardiomyopathy (Systemic Infusion of Expanded CD133+ Cells and Expanded CD133+ Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI)
46. Reducing cardiac ischemic events in patients with ACS: prasugrel versus clopidogrel
47. Findings from Research Institute of Experimental Medicine Provides New Data about Myocardial Ischemia (Antiarrhythmic effect of uridine and uridine-5'-monophosphate in acute myocardial ischemia)
48. Osteoprotegerin, thiazolidinediones treatment, and silent myocardial ischemia in type 2 diabetic patients
49. Choice within sulfonylurea drugs in ischemic heart disease patients
50. CARDIAMP CELL THERAPY RECEIVES FDA APPROVAL FOR PIVOTAL TRIAL IN CHRONIC MYOCARDIAL ISCHEMIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.